A review of databases, resources, and online search tools that allow for monitoring health R&D activities

Similar documents
Introduction to the Technical Supplements

Introduction to the Technical Supplements

Supporting countries for HRH development: from dialogue to action

HIV/AIDS Programme USER GUIDE DRUG REGULATORY STATUS DATABASE (DRS) Version 2

SHIPPERS PROGRAMME Introduction Infectious Substances Shipping Training

PROPOSAL FOR UPDATING THE DEFINITION OF STRINGENT REGULATORY AUTHORITY

Results of WHO survey on demand for testing in WHO Scheme to Evaluate Household Water Treatment Technologies

GUIDELINES ON SUBMISSION OF DOCUMENTATION FOR PREQUALIFICATION OF FINISHED PHARMACEUTICAL PRODUCTS APPROVED BY STRINGENT REGULATORY AUTHORITIES

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT

Guide for Documenting and Sharing Best Practices. in Health Programmes

BURULI ULCER. A guide for field health workers

Working document QAS/11.415/Rev. 1 August 2011 RESTRICTED DRAFT FOR COMMENT

Meeting of the Eastern Mediterranean Research Ethics Review Committee

A Review of the PA-824 Patent Landscape

Consultation on health workforce development in the Eastern Mediterranean Region

GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES

Working document QAS/ June 2011 RESTRICTED DRAFT FOR COMMENT

Pentamidine isetionate Pentamidine isetionate for injection

Requirements for Yellow Fever Vaccine (Requirements for Biological Substances No. 3) Proposed Amendment

Expert consultation on the development of a plan of action for food safety in the Eastern Mediterranean Region

Water and Health UNITED NATIONS

DRAFT NOTES ON THE CONDUCT OF SOLUBILITY STUDIES

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

Cost savings of switching private sector consumption from originator brand medicines to generic equivalents

ABRIDGED PREQUALIFICATION ASSESSMENT. Prequalification of In Vitro Diagnostics

Pan African Clinical Trials Registry (PACTR) Amber Abrams, Project Manager South African Cochrane Centre

International Traffic Safety

CONCEPT PAPER FOR COMMENT

Guideline on Good Pharmacovigilance Practices Module V- Pharmacovigilance System Master File

Regional meeting on food safety

HeRAMS Health Resources Availability Mapping System

DACLATASVIR TABLETS (DACLATASVIRI COMPRESSI) Proposal for The International Pharmacopoeia. (May 2018)

OVERARCHING FRAMEWORK UNEP GLOBAL MERCURY PARTNERSHIP

Joint statement on public disclosure of results from clinical trials

THE INTERNATIONAL PHARMACOPOEIA

Biological Qualifier An INN Proposal. Programme on International Nonproprietary Names (INN)

WHO International Clinical Trials Registry Platform (ICTRP)

REVISED DRAFT FOR COMMENT

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON ARTEMETHER AND LUMEFANTRINE CAPSULES REVISED DRAFT FOR DISCUSSION

WHO GLOBAL BENCHMARKING TOOL (GBT) FOR EVALUATION OF NATIONAL REGULATORY SYSTEM OF MEDICAL PRODUCTS

WHO Outbreak Communication Guidelines

Meeting of the Eastern Mediterranean Research Ethics Review Committee

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION

Draft proposal for The International Pharmacopoeia

Guidelines for price discounts of single-source pharmaceuticals

ADVAC ALUMNI MEETING DURING SAGE

Group Forest Management Certification Requirements

UNODC/CND/EG.1/2010/CRP1

SIXTY-THIRD WORLD HEALTH ASSEMBLY. Partnerships

Millions of people still die every year from poverty-related diseases

POLICY POSITION ON NAMING OF BIOTECHNOLOGY-DERIVED THERAPEUTIC PROTEINS. October 31, 2006

UNAIDS 2015 REPORT. operational guidelines for selecting indicators for the HIV response

Guidelines for auditing management systems

Regional training workshop on sanitation/ wastewater safety planning

SUMMARY DOCUMENT FOR FROM PIPELINE TO PRODUCT: MALARIA R&D FUNDING NEEDS INTO THE NEXT DECADE

Swiss TPH Summer Symposium

Critical Path to TB Drug Regimens (CPTR)

This document is a preview generated by EVS

STATUS OF REVIEWS, AUTHORIZATIONS AND OVERSIGHT FOR CLINICAL TRIALS IN THE WHO AFRICAN REGION. Technical Document

Enhancing capacity to apply research evidence in policy making Call for Expressions of Interest, from teams based in low income countries

Transform Clinical Research Into Value-Based Personalized Care

STATUS OF REVIEWS, AUTHORIZATIONS AND OVERSIGHT FOR CLINICAL TRIALS IN THE WHO AFRICAN REGION. Technical Document

DEVELOP BANKABLE RENEWABLE ENERGY PROJECTS

Review of the Member State mechanism on substandard/spurious/falsely-labelled/ falsified/counterfeit medical products

COORDINATION AND PRIORITY SETTING IN R&D TO MEET HEALTH NEEDS IN DEVELOPING COUNTRIES

EXECUTIVE SUMMARY EXECUTIVE SUMMARY. Global funding for neglected disease R&D increased for the first time since The survey.

Call for expression of interest: Identifying the building blocks for the establishment of a global platform for co-operatives for health

WORLD HEALTH ORGANIZATION. Guidelines on working with the private sector to achieve health outcomes

EBOLA VIRUS DISEASE FLIP BOOK TRAINING GOWHO GO PRE-DEPLOYMENT TRAINING

Guidelines for auditing management systems

International Code of Conduct on the Distribution and Use of Pesticides

Evaluation: annual report

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION

Quick Guide - SAP Mobile Secure Cloud

Practice of States and international organizations in registering space objects: Elements of conclusions of the Working Group

Bio-Pharma: China A Look at The FUTURE: 4 th & 5 th Generation Global Strategies

INTERNATIONAL STANDARD

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva, 29 October to 2 November 2018 SECOND REPLACEMENT SEED STOCK FOR MRC-5 CELLS

Process. Content. Dr Tedros Adhanom Ghebreyesus Director-General World Health Organization Avenue Appia Geneva 27 Switzerland

The PSM Consultant will work in close collaboration with UNDP Country Office staff, governments, UN agencies in the areas of their expertise.

IBM Clinical Development

Mastercard Engage Directory for Digital Wallets

Why Culture Matters in Cancer Research

fact sheet 7 Regulator Capacity for Biologics in Low-and- Middle Income Countries

ISO Freight containers RFID cargo shipment tag system

WHO Prequalification Programmes

Selection and use of Ebola in vitro diagnostic (IVD) assays

Requirements for the establishment of pest free areas

Information for clinical researchers on transparency of clinical trial reporting

INTERNATIONAL STANDARDS FOR PHYTOSANITARY MEASURES PRINCIPLES OF PLANT QUARANTINE AS RELATED TO INTERNATIONAL TRADE

MarketsandMarkets. Publisher Sample

INTERNATIONAL HEALTH REGULATIONS (2005) MONITORING AND EVALUATION FRAMEWORK

ISO 2018 COPYRIGHT PROTECTED DOCUMENT All rights reserved. Unless otherwise specified, or required in the context of its implementation, no part of th

FDA Driving Biomedical Product Innovation

Data & Materials Sharing Agreement. Collaboration for AIDS Vaccine Discovery. Clinical Trials Data Sharing Addendum & Related Information

Clinical Trial Transparency UK perspective

Unistar PRO sharpens its competitive edge with SAP and Lenovo

Procedural advice on publication of information on negative opinions and refusals of marketing authorisation applications for human medicinal products

Transcription:

A review of databases, resources, and online search tools that allow for monitoring health R&D activities Explanation of methods and description of main results Accompanying the Excel file Review of data sources that allow for monitoring of health R&D. Developed by Klara Henderson

A review of databases, resources, and online search tools that allow for monitoring health R&D activities World Health Organization 2016 All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications whether for sale or for noncommercial distribution should be addressed to Publications, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. This published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use, or be held to be responsible for its accuracy or completeness. This publication presents data, information, and conclusions of an independent consultant and/or advisor to the World Health Organization, and does not necessarily represent the decisions or the stated policy of the World Health Organization. WHO/HIS/IER/REK/16.01 A review of databases, resources, and online search tools that allow for monitoring health R&D activities ii

Background On 27 May 2013, the Sixty-sixth World Health Assembly passed resolution WHA66.22, 1 which, among other things, requests the World Health Organization (WHO) to establish a global health research and development observatory. The Global Observatory on Health R&D, envisioned to be launched in 2016, 2 will be a platform that collates information on health research and development (R&D), with a view to contributing to the identification of gaps and opportunities for health R&D and the defining of priorities for new R&D investments based on public health needs. The Global Observatory on Health R&D will aim to provide a centralized and comprehensive source of data on what health R&D is being conducted globally, where it is being conducted, by whom and how, and it will bring together information from a wide range of data sources to provide this overview. Resolution 66.22 asks WHO to build on national and regional observatories (or equivalent functions) and existing data collection mechanisms in doing so. Therefore, as part of the preparatory steps in developing the Global Observatory on Health R&D, a review of current databases, resources, and online search tools that allow for monitoring health R&D activities was commissioned. This report and the accompanying Excel database are the result of that review. Objective To develop a database of resources, databases and online search tools that provide insight into how much and what kind of health R&D is being conducted for different components and stages of the health R&D process, thus allowing for monitoring of health R&D activities. Theoretical framework A framework for information resources that allows for monitoring of health R&D activities was recently suggested by Røttingen et al, 3 who proposed that health R&D can be monitored by identifying data sources for health R&D inputs, processes and outputs. Below, in Figure 1, these three categories are listed, including the associated data source types that have been included in this review. While no publicly available comprehensive database exists covering all of these elements in combination, the database developed for this review allows researchers to monitor health R&D in terms of funding, research projects, pipelines, patents and publications. Methodology Data collection A list was developed through multiple methods. First, a broad search for articles and websites was undertaken, using the terms health AND research and development AND 1 Resolution WHA66.22. Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination. In: Sixty-sixth World Health Assembly, Geneva, 20-27 May 2013. Resolutions and decisions, annexes. Geneva: World Health Organization; 2013:48 51 (WHA66/2013/REC/1; http://apps.who.int/gb/ebwha/pdf_files/wha66-rec1/a66_rec1-en.pdf, accessed 8 October 2015) 2 Global Observatory on Health R&D. World Health Organization: www.who.int/research-observatory 3 Røttingen JA, Regmi S, Young AJ, Viergever RF, Årdal C, Guzman J et al. Mapping of available health research and development data: what s there, what s missing and what role is there for a global observatory? Lancet 2013;382(9900):1286 307. A review of databases, resources, and online search tools that allow for monitoring health R&D activities 1

[databases OR repositories OR clearinghouse OR observatories] in Scopus and Google Advanced Search. References to specific databases, repositories, clearinghouses or observatories within articles were identified and listed in an interim list. Specific databases, repositories, clearinghouses, observatories or data sources found through the Google Advanced Search were also added to the interim list. Second, websites identified through references found in published policy documents in the field of health R&D were added to the interim list. Third, websites of organizations known to work in the field of global health R&D were assessed and incorporated, including key funders of health R&D, researchers such as product development partnerships, 4 industry bodies (e.g. the International Federation of Pharmaceutical Manufacturers and Associations [IFPMA]), and those working in global health R&D advocacy (e.g. BIO Ventures for Global Health, Global Health Technologies Coalition, Access to Medicines, AIDS Vaccine Advocacy Coalition, Council on Health Research for Development, Policy Cures). Finally, a search of the entries in the Registry of Open Access Repositories 5 under subject = medicine was conducted, and relevant repositories included in the interim list. The initial interim list was then used to identify, verify and validate the databases, repositories, clearinghouses, observatories or data sources for inclusion in the final list. Inputs Funding data Health researchers Organizations Processes Clinical trial data Research projects Product pipelines Outputs Publications Product registration status Patents Figure 1. Potential indicators for monitoring health R&D and associated data source types Review Once each item in the interim list was identified, a validation step was undertaken. This included determining the scope and structure of the material available. Each site was reviewed with the following characteristics in mind: relevance of scope; specific types of data provided; accessibility (restricted or not); geographic scope; searchability and disease/health area specificity. If the site included a search function, a simple search was 4 Product Development Partnerships Funders Group: http://pdpfundersgroup.org/pdps.html 5 Registry of Open Access Repositories: http://roar.eprints.org A review of databases, resources, and online search tools that allow for monitoring health R&D activities 2

undertaken (usually on the term malaria or malaria vaccines) to validate the scope and utility of the site and see the structure of the returned results. Databases and websites were retained if they were within the scope of health R&D and allowed for monitoring of health R&D, were current and functioning, but were discarded from the list if they did not meet these criteria. Table 1 (also Figure 1) lists the data source types that were included in the review and provides descriptions of these, examples, and number of sources identified. The full list of data sources identified in this review is provided in the Excel file that accompanies this document, entitled Review of data sources that allow for monitoring of health R&D. A review of databases, resources, and online search tools that allow for monitoring health R&D activities 3

Table 1. Data sources included in the review: type, description, examples and number Data source type Description Examples Funding data Health researchers Organizations Clinical trial data Research projects Funding data including: aggregated country level R&D expenditure on medical and health sciences across a number of countries; investment projectlevel data from multiple funders organized by disease area; project-level funding data from a single organization; funding data for a single disease; investments by the pharmaceutical industry. Data on number of health researchers are available at country level, and cannot be disaggregated by disease. Organizational data allow identification of individual funders or recipients/ research organizations involved in research processes, product development and outputs. Clinical trials data ranging from listings of trials for specific disease areas to comprehensive all-inclusive clinical trial databases. Research project data capture any database that reports and describes health R&D projects. (Many of these also list funding associated with the research.) Country-level aggregated R&D funding data e.g. OECD Science, Technology and R&D Statistics Project level data organized by disease e.g. G-FINDER, ResIn Single organization level data e.g. Wellcome Trust Grants, NIH RePORTER UNESCO Institute of Statistics 4 EU Industrial R&D Investment Scoreboard G-FINDER BVGH s Neglected Disease Product Pipelines Access to Medicine Index 40 TB drugs clinical trials in development International Clinical Trials Registry Platform (ICTRP) 15 NIH s World RePORT Country specific examples: Fiji Health Research Portal, South African National Health Research Database 46 Number of databases or websites covering this data source type 41 A review of databases, resources, and online search tools that allow for monitoring health R&D activities 4

Data source type Description Examples Product pipelines Publications Product registration status Many of the product pipeline databases and websites are disease (and/or disease + product) specific with a focus on diseases affecting those in low and middle-income countries. There are a few user-pays services that include product pipeline information. Publication databases ranging from listings of specific publications from an organization to databases covering a country or a region through to comprehensive databases with a global scope. Some are subscription services only and/or require institutional access. These listings provide information on registration status of products across a number of countries. BVGH s Neglected Disease Product Pipelines WHO Initiative for Vaccine Research (IVR) publishes the Rainbow Table (list of malaria vaccine candidates) Number of databases or websites covering this data source type 29 Organization specific examples: COHRED publications, TB Alliance publications Region specific examples: African Index Medicus, Index Medicus for South-East Asia Region Comprehensive examples: PubMed, Directory of Open Access Journals, POPLINE, EMBASE (Excerpta Medica Database) 73 Access to registration status of products registered at FDA, EMA, WHO Prequalified list Access to Medicine Index provides numerical data on the number of products registered by disease area (focusing on diseases with the greatest DALYs) Individual country product registration status 30 A review of databases, resources, and online search tools that allow for monitoring health R&D activities 5

Data source type Description Examples Patents Databases here either provide statistics on the number of patents by country or data on actual patents. OECD Science, Technology and R&D Statistics provides counts of patents per country PATENTSCOPE provides details of actual patents, updated daily, covering international and national patent documents 8 Number of databases or websites covering this data source type Note: numbers in this table do not add up to the total number of data sources listed in the Excel file because several databases fall in multiple data source categories. Limitations The nature of this list is dynamic; new sources will be developed and existing sources may be disbanded. It will be important to consistently maintain the list to reflect such changes. The list includes predominately English language websites, although there are some other language sites particularly for country or region specific medical publications and product registration. Notes As with all links on the internet, updates to materials occur regularly; these may result in greater access to up-to-date information or may result in the specified URL link no longer pointing to the most recent material. A review of databases, resources, and online search tools that allow for monitoring health R&D activities 6